The mitochondrial ubiquitin ligase MARCH5 resolves MAVS aggregates during antiviral signalling

Nature Communications

Volumn 6, Issue , 2015, Pages

  Yoo, Young Suk ^a,b   Park, Yong Yea ^a   Kim, Jae Hoon ^c   Cho, Hyeseon ^d   Kim, Song Hee ^a   Lee, Ho Soo ^a,b   Kim, Tae Hwan ^c   Kim, You Sun ^a,b   Lee, Youngsoo ^a,b   Kim, Chul Joong ^c   Jung, Jae U ^e   Lee, Jong Soo ^c   Cho, Hyeseong ^a,b  

^a Ajou University School of Medicine   (South Korea)

^b Ajou University   (South Korea)

^c Chungnam National University   (South Korea)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; MARCH5 PROTEIN; MITOCHONDRIAL ANTIVIRAL SIGNALLING PROTEIN; MITOCHONDRIAL ENZYME; PROTEASOME; PROTEIN AGGREGATE; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; IPS-1 PROTEIN, MOUSE; MARCH5 PROTEIN, HUMAN; MARCH5 PROTEIN, MOUSE; MEMBRANE PROTEIN; MITOCHONDRIAL PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; UBIQUITIN; UBIQUITIN PROTEIN LIGASE; VISA PROTEIN, HUMAN;

ANTIMICROBIAL ACTIVITY; CELLS AND CELL COMPONENTS; ENZYME ACTIVITY; IMMUNE RESPONSE; IMMUNE SYSTEM; METABOLISM; MITOCHONDRION; MUTATION; PROTEIN; VIRAL DISEASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CASPASE ACTIVATION AND RECRUITMENT DOMAIN; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; MITOCHONDRION; MOUSE; NONHUMAN; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RING FINGER MOTIF; RNA VIRUS; SIGNAL TRANSDUCTION; UBIQUITINATION; VIRUS REPLICATION; ANIMAL; C57BL MOUSE; ENZYMOLOGY; HEK293 CELL LINE; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; RNA VIRUS INFECTION;

MUS; RNA VIRUSES;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; HEK293 CELLS; HUMANS; IMMUNITY, INNATE; INTERFERON TYPE I; MEMBRANE PROTEINS; MICE, INBRED C57BL; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; RNA VIRUS INFECTIONS; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES;

EID: 84938809934     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms8910     Document Type: Article

References (56)

1. Wang, X., Herr, R. A. & Hansen, T. Viral and cellular MARCH ubiquitin ligases and cancer. Semin. Cancer Biol. 18, 441-450 (2008).
2. Ohmura-Hoshino, M. et al. A novel family of membrane-bound E3 ubiquitin ligases. J. Biochem. 140, 147-154 (2006).
3. Bartee, E., Mansouri, M., Hovey Nerenberg, B. T., Gouveia, K. & Fruh, K. Downregulation of major histocompatibility complex class I by human ubiquitin ligases related to viral immune evasion proteins. J. Virol. 78, 1109-1120 (2004).
4. Ishido, S., Goto, E., Matsuki, Y. & Ohmura-Hoshino, M. E3 ubiquitin ligases for MHC molecules. Curr. Opin. Immunol. 21, 78-83 (2009).
5. Nathan, J. A. & Lehner, P. J. The trafficking and regulation of membrane receptors by the RING-CH ubiquitin E3 ligases. Exp. Cell Res. 315, 1593-1600 (2009).
6. Jahnke, M., Trowsdale, J. & Kelly, A. P. Ubiquitination of HLA-DO by MARCH family E3 ligases. Eur. J. Immunol. 43, 1153-1161 (2013).
7. Oh, J. et al. MARCH1-mediated MHCII ubiquitination promotes dendritic cell selection of natural regulatory T cells. J. Exp. Med. 210, 1069-1077 (2013).
8. Nagashima, S., Tokuyama, T., Yonashiro, R., Inatome, R. & Yanagi, S. Roles of mitochondrial ubiquitin ligase MITOL/MARCH5 in mitochondrial dynamics and diseases. J. Biochem. 155, 273-279 (2014).
9. Karbowski, M., Neutzner, A. & Youle, R. J. The mitochondrial E3 ubiquitin ligase MARCH5 is required for Drp1 dependent mitochondrial division. J. Cell Biol. 178, 71-84 (2007).
10. Park, Y. Y. et al. Loss of MARCH5 mitochondrial E3 ubiquitin ligase induces cellular senescence through dynamin-related protein 1 and mitofusin 1. J. Cell Sci. 123, 619-626 (2010).
11. Park, Y. Y. & Cho, H. Mitofusin 1 is degraded at G2/M phase through ubiquitylation by MARCH5. Cell Div. 7, 25 (2012).
12. Yonashiro, R. et al. A novel mitochondrial ubiquitin ligase plays a critical role in mitochondrial dynamics. EMBO J. 25, 3618-3626 (2006).
13. Yonashiro, R. et al. Mitochondrial ubiquitin ligase MITOL blocks S-nitrosylated MAP1B-light chain 1-mediated mitochondrial dysfunction and neuronal cell death. Proc. Natl Acad. Sci. USA 109, 2382-2387 (2012).
14. Sugiura, A. et al. A mitochondrial ubiquitin ligase MITOL controls cell toxicity of polyglutamine-expanded protein. Mitochondrion 11, 139-146 (2011).
15. Yonashiro, R. et al. Mitochondrial ubiquitin ligase MITOL ubiquitinates mutant SOD1 and attenuates mutant SOD1-induced reactive oxygen species generation. Mol. Biol. Cell 20, 4524-4530 (2009).
16. Park, Y. Y., Nguyen, O. T., Kang, H. & Cho, H. MARCH5-mediated quality control on acetylated Mfn1 facilitates mitochondrial homeostasis and cell survival. Cell Death Dis. 5, e1172 (2014).
17. Yoneyama, M. et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5, 730-737 (2004).
18. Kato, H. et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441, 101-105 (2006).
19. Takeuchi, O. & Akira, S. MDA5/RIG-I and virus recognition. Curr. Opin. Immunol. 20, 17-22 (2008).
20. Moresco, E. M. & Beutler, B. LGP2: positive about viral sensing. Proc. Natl Acad. Sci. USA 107, 1261-1262 (2010).
21. Hou, F. et al. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 146, 448-461 (2011).
22. Moresco, E. M., Vine, D. L. & Beutler, B. Prion-like behavior of MAVS in RIG-I signaling. Cell Res. 21, 1643-1645 (2011).
23. Cai, X. et al. Prion-like polymerization underlies signal transduction in antiviral immune defense and inflammasome activation. Cell 156, 1207-1222 (2014).
24. Seth, R. B., Sun, L., Ea, C. K. & Chen, Z. J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122, 669-682 (2005).
25. Kawai, T. et al. IPS-1, an adaptor triggering RIG-I-and Mda5-mediated type I interferon induction. Nat. Immunol. 6, 981-988 (2005).
26. Xu, L. G. et al. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 19, 727-740 (2005).
27. Moore, C. B. et al. NLRX1 is a regulator of mitochondrial antiviral immunity. Nature 451, 573-577 (2008).
28. You, F. et al. PCBP2 mediates degradation of the adaptor MAVS via the HECT ubiquitin ligase AIP4. Nat. Immunol. 10, 1300-1308 (2009).
29. Jia, Y. et al. Negative regulation of MAVS-mediated innate immune response by PSMA7. J. Immunol. 183, 4241-4248 (2009).
30. Paz, S. et al. A functional C-terminal TRAF3-binding site in MAVS participates in positive and negative regulation of the IFN antiviral response. Cell Res. 21, 895-910 (2011).
31. Wang, Y., Tong, X. & Ye, X. Ndfip1 negatively regulates RIG-I-dependent immune signaling by enhancing E3 ligase Smurf1-mediated MAVS degradation. J. Immunol. 189, 5304-5313 (2012).
32. Wang, P. et al. UBXN1 interferes with Rig-I-like receptor-mediated antiviral immune response by targeting MAVS. Cell Rep. 3, 1057-1070 (2013).
33. Pan, Y. et al. Smurf2 negatively modulates RIG-I-dependent antiviral response by targeting VISA/MAVS for ubiquitination and degradation. J. Immunol. 192, 4758-4764 (2014).
34. Brubaker, S. W., Gauthier, A. E., Mills, E. W., Ingolia, N. T. & Kagan, J. C. A bicistronic MAVS transcript highlights a class of truncated variants in antiviral immunity. Cell 156, 800-811 (2014).
35. Sugiura, A. et al. MITOL regulates endoplasmic reticulum-mitochondria contacts via Mitofusin2. Mol. Cell 51, 20-34 (2013).
36. Xu, H. et al. Structural basis for the prion-like MAVS filaments in antiviral innate immunity. eLife 3, e01489 (2014).
37. Wu, B. et al. Molecular imprinting as a signal-activation mechanism of the viral RNA sensor RIG-I. Mol. Cell 55, 511-523 (2014).
38. Fruh, K., Bartee, E., Gouveia, K. & Mansouri, M. Immune evasion by a novel family of viral PHD/LAP-finger proteins of gamma-2 herpesviruses and poxviruses. Virus Res. 88, 55-69 (2002).
39. Goto, E. et al. c-MIR, a human E3 ubiquitin ligase, is a functional homolog of herpesvirus proteins MIR1 and MIR2 and has similar activity. J. Biol. Chem. 278, 14657-14668 (2003).
40. Lehner, P. J., Hoer, S., Dodd, R. & Duncan, L. M. Downregulation of cell surface receptors by the K3 family of viral and cellular ubiquitin E3 ligases. Immunol. Rev. 207, 112-125 (2005).
41. Stevenson, P. G., Efstathiou, S., Doherty, P. C. & Lehner, P. J. Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses. Proc. Natl Acad. Sci. USA 97, 8455-8460 (2000).
42. Coscoy, L. & Ganem, D. Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc. Natl Acad. Sci. USA 97, 8051-8056 (2000).
43. Means, R. E., Lang, S. M. & Jung, J. U. The Kaposi's sarcoma-associated herpesvirus K5 E3 ubiquitin ligase modulates targets by multiple molecular mechanisms. J. Virol. 81, 6573-6583 (2007).
44. Hoer, S., Smith, L. & Lehner, P. J. MARCH-IX mediates ubiquitination and downregulation of ICAM-1. FEBS Lett. 581, 45-51 (2007).
45. Chen, R., Li, M., Zhang, Y., Zhou, Q. & Shu, H. B. The E3 ubiquitin ligase MARCH8 negatively regulates IL-1beta-induced NF-kappaB activation by targeting the IL1RAP coreceptor for ubiquitination and degradation. Proc. Natl Acad. Sci. USA 109, 14128-14133 (2012).
46. Shi, H. X. et al. Mitochondrial ubiquitin ligase MARCH5 promotes TLR7 signaling by attenuating TANK action. PLoS Pathog. 7, e1002057 (2011).
47. Gack, M. U. et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIGI-mediated antiviral activity. Nature 446, 916-920 (2007).
48. Zhong, B. et al. The ubiquitin ligase RNF5 regulates antiviral responses by mediating degradation of the adaptor protein MITA. Immunity 30, 397-407 (2009).
49. Baril, M., Racine, M. E., Penin, F. & Lamarre, D. MAVS dimer is a crucial signaling component of innate immunity and the target of hepatitis C virus NS3/4A protease. J. Virol. 83, 1299-1311 (2009).
50. Ye, J. & Maniatis, T. A prion-like trigger of antiviral signaling. Cell 146, 348-350 (2011).
51. Peisley, A., Wu, B., Xu, H., Chen, Z. J. & Hur, S. Structural basis for ubiquitinmediated antiviral signal activation by RIG-I. Nature 509, 110-114 (2014).
52. Liu, S. et al. MAVS recruits multiple ubiquitin E3 ligases to activate antiviral signaling cascades. eLife 2, e00785 (2013).
53. Paz, S. et al. Ubiquitin-regulated recruitment of IkappaB kinase epsilon to the MAVS interferon signaling adapter. Mol. Cell Biol. 29, 3401-3412 (2009).
54. Schott, D. H., Cureton, D. K., Whelan, S. P. & Hunter, C. P. An antiviral role for the RNA interference machinery in Caenorhabditis elegans. Proc. Natl Acad. Sci. USA 102, 18420-18424 (2005).
55. Perez, J. T., Garcia-Sastre, A. & Manicassamy, B. Insertion of a GFP reporter gene in influenza virus. Curr. Protoc. Microbiol. Chapter 15, Unit 15G 14, (2013).
56. Kim, Y. et al. A library of TAL effector nucleases spanning the human genome. Nature biotechnology 31, 251-258 (2013).